Welcome to our dedicated page for Parkervision SEC filings (Ticker: PRKR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page compiles U.S. Securities and Exchange Commission (SEC) filings for ParkerVision, Inc. (PRKR), a Florida corporation focused on radio-frequency (RF) technologies for advanced wireless communication systems. Through its periodic and current reports, ParkerVision provides detailed information on its operations, financial condition, litigation posture, and capital-raising activities.
Investors can use ParkerVision’s annual reports on Form 10-K and quarterly reports on Form 10-Q to review its RF technology and licensing focus, operating expenses, net losses, contingent payment obligations, and cash flows. These filings also include risk factor discussions that the company references in its press releases, covering topics such as outcomes of patent litigation, interpretations of patent law and claim scope, decisions by the Patent Trial and Appeal Board (PTAB), and market conditions affecting financing.
Current reports on Form 8-K are particularly important for tracking material events. Recent 8-K filings describe registered direct offerings of common stock under ParkerVision’s effective shelf registration statement on Form S-3, including sales to accredited investors and to a director. These filings outline subscription agreements, offering prices, aggregate purchase amounts, and legal opinions regarding the issuance of securities. Other 8-Ks furnish earnings press releases that summarize quarterly and year-to-date financial results and provide context for changes in operating expenses and contingent payment obligations.
Through this filings page, users can access ParkerVision’s real-time updates as they are filed with EDGAR, including 10-K, 10-Q, and 8-K reports, as well as registration statements and prospectus supplements related to its shelf registration. AI-powered tools on the platform can help summarize lengthy filings, highlight key sections such as litigation disclosures, capital structure changes, and risk factors, and make it easier to interpret complex legal and financial language without replacing the full primary documents.
ParkerVision, Inc. completed a registered direct offering of 4,761,905 shares of common stock to board member Lewis H. Titterton, Jr. for $1,000,000, priced at $0.21 per share, equal to the last reported OTCQB sale price on November 14, 2025. The company received the full amount with no underwriting or placement fees.
Shares outstanding increase from 121,549,398 to 126,311,303, and the transaction causes immediate dilution, with pro forma net tangible book value rising from approximately $(0.42) to $(0.40) per share. Management plans to use the net proceeds for working capital and other general corporate purposes, including litigation fees and expenses, as ParkerVision continues to focus on enforcing its RF patent portfolio.
ParkerVision, Inc. (PRKR) completed a registered offering of 4,761,905 shares of common stock for total proceeds of $1,000,000. The shares were sold on November 17, 2025 to company director Lewis H. Titterton, Jr. at $0.21 per share, matching the last reported sale price of the stock on the OTCQB Venture Market on November 14, 2025, under a subscription agreement dated that day. The issuance was made from ParkerVision’s Form S-3 shelf registration statement and a prospectus supplement that set the final terms. The company did not use underwriters or placement agents and paid no commissions or fees in connection with this transaction.
ParkerVision, Inc. entered into a subscription agreement for 4,761,905 shares of its common stock with director Lewis H. Titterton, Jr. for a total of $1,000,000. The shares are priced at $0.21 per share, matching the last reported sale price of the stock on the OTCQB Venture Market on November 14, 2025. The transaction is being conducted directly by the company without an underwriter, under an existing Form S-3 shelf registration. Because the buyer is a board member, the deal was reviewed and approved by disinterested directors under Florida corporate law, with closing expected on or before November 18, 2025.
ParkerVision, Inc. has filed a prospectus supplement that allows selling shareholders to resell up to 9,387,500 shares of common stock, primarily from previously issued shares and shares underlying convertible notes and options. The company will not receive proceeds from these resales, and would receive only up to $42,620 if certain options are exercised for cash.
Attached to the supplement is ParkerVision’s latest quarterly report, showing a net loss of about $7.4 million for the nine months ended September 30, 2025 and no revenue. Cash and cash equivalents were roughly $0.9 million against current liabilities of about $2.9 million, including $1.6 million of convertible debt due within a year, and large long-term contingent payment obligations. Management states these conditions raise substantial doubt about the company’s ability to continue as a going concern without new licensing wins, successful litigation outcomes or additional financing.
ParkerVision (PRKR) filed its Q3 2025 10‑Q, reporting no revenue and a net loss of $1.966 million for the quarter. For the nine months ended September 30, 2025, the company recorded a net loss of $7.399 million and used $4.071 million in operating cash.
Cash and cash equivalents were $0.901 million as of September 30, 2025, with a working capital deficit of $1.8 million. The company disclosed substantial doubt about its ability to continue as a going concern. Current liabilities totaled $2.946 million, including $1.625 million of convertible notes due within twelve months. Long‑term liabilities include a secured contingent payment obligation of $40.781 million and unsecured contingent payment obligations of $6.392 million. Shareholders’ deficit was $49.837 million.
The company filed a $25 million Form S‑3 shelf in May 2025 and has not sold securities under it. Common shares outstanding were 120,394,000 at quarter‑end and 121,424,398 as of November 7, 2025. Subsequent to quarter‑end, the Federal Circuit granted an expedited schedule in the Qualcomm appeal.
ParkerVision, Inc. furnished an 8-K announcing it issued a press release reporting financial and operating results for the three and nine months ended September 30, 2025. The press release is attached as Exhibit 99.1 and incorporated by reference.
The company states the information, including Exhibit 99.1, is “furnished” and not “filed” under the Exchange Act, and will not be incorporated into Securities Act filings unless specifically referenced.
Director Lewis H. Titterton reported option grants and subsequent exercises that change his holdings in Parkervision Inc. (PRKR). On 10/07/2025 he reported two nonqualified stock option transactions: 525,000 options at an exercise price of $0.18 and 275,000 options at $0.20. The first option series vests in equal quarterly installments beginning 01/27/2024; the second vested in four equal quarterly increments beginning 05/01/2024 and became fully exercisable on 02/01/2025. Following these reported transactions, Mr. Titterton beneficially owns 3,816,265 shares of common stock. The filings show the options underlie 525,000 and 275,000 common shares respectively, with the $0.18 options expiring 11/18/2028.